Dicerna Pharmaceuticals, Inc.Equity-NMS: DRNA
Equity-NMS: DRNA
$38.22
NA
(28 Dec)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$38.22
Open
$38.22
Today’s high
$38.24
Today’s low
$38.21
52W low
$19.06
52W high
$40.14
5Y
57.60%
EPS (TTM)
-1.63
Shares O/S
72.10M
Market cap
2.98B
Insights
DRNA has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
DRNA price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to silence selectively genes that cause or contribute to disease. The Company's GalXC RNAi technology Platform consists of its liver-targeted GalXC technology and GalXC-Plus technology for tissues outside the liver.

The Company's product line includes nedosiran, RG6346, belcesiran, and DCR-AUD. Its lead product candiadate nedosiran is a RNAi drug candidate developed for the treatment of hyperoxaluria (PH). The RG6346 for the treatment of chronic hepatitis B virus (HBV) infection. The belcesiran for the treatment of alpha-1 antitrypsin deficiency-associated liver disease (AATLD). The DCR-AUD for the treatment of alcohol use disorder (AUD). .


FAQs

Can I buy Dicerna Pharmaceuticals, Inc. shares in India?
How to buy Dicerna Pharmaceuticals, Inc. shares in India?
What is the share price of Dicerna Pharmaceuticals, Inc.?
What is the Market Capitalization of Dicerna Pharmaceuticals, Inc.?
What is the PE ratio of Dicerna Pharmaceuticals, Inc.?
Is Dicerna Pharmaceuticals, Inc. a good stock to buy?
In which sector / industry does Dicerna Pharmaceuticals, Inc. operate?